S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
WARNING: Mandatory U.S. Dollar Recall is Weeks Away (Ad)
MarketBeat Week in Review – 9/18 - 9/22
The federal government is headed into a shutdown. What does it mean, who's hit and what's next?
The single greatest medical breakthrough of all time? (Ad)
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
The single greatest medical breakthrough of all time? (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Auto workers still have room to expand their strike against car makers. But they also face risks
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
WARNING: Mandatory U.S. Dollar Recall is Weeks Away (Ad)
MarketBeat Week in Review – 9/18 - 9/22
The federal government is headed into a shutdown. What does it mean, who's hit and what's next?
The single greatest medical breakthrough of all time? (Ad)
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
The single greatest medical breakthrough of all time? (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Auto workers still have room to expand their strike against car makers. But they also face risks
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
WARNING: Mandatory U.S. Dollar Recall is Weeks Away (Ad)
MarketBeat Week in Review – 9/18 - 9/22
The federal government is headed into a shutdown. What does it mean, who's hit and what's next?
The single greatest medical breakthrough of all time? (Ad)
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
The single greatest medical breakthrough of all time? (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Auto workers still have room to expand their strike against car makers. But they also face risks
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
3 Reasons This Sleeping Giant Is About To Wake Up
WARNING: Mandatory U.S. Dollar Recall is Weeks Away (Ad)
MarketBeat Week in Review – 9/18 - 9/22
The federal government is headed into a shutdown. What does it mean, who's hit and what's next?
The single greatest medical breakthrough of all time? (Ad)
Birthplace of the atomic bomb braces for its biggest mission since the top-secret Manhattan Project
At UN, African leaders say enough is enough: They must be partnered with, not sidelined
The single greatest medical breakthrough of all time? (Ad)
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Auto workers still have room to expand their strike against car makers. But they also face risks
NASDAQ:OTLK

Outlook Therapeutics (OTLK) Earnings Date, Estimates & Call Transcripts

$0.21
0.00 (0.00%)
(As of 09/22/2023 ET)
Compare
Today's Range
$0.20
$0.21
50-Day Range
$0.20
$1.78
52-Week Range
$0.20
$2.03
Volume
3.11 million shs
Average Volume
14.98 million shs
Market Capitalization
$54.36 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.83

Earnings Summary

Upcoming
Earnings Date
Nov. 13Estimated
Actual EPS
(Aug. 14)
-$0.08 Missed By -$0.04
Consensus EPS
(Aug. 14)
-$0.04
Skip Charts & View Estimated and Actual Earnings Data

OTLK Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

OTLK Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Outlook Therapeutics Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20231($0.06)($0.06)($0.06)
Q3 20233($0.06)($0.03)($0.04)
Q4 20233($0.07)($0.05)($0.06)
20237($0.19)($0.14)($0.16)
Q1 20243($0.05)($0.02)($0.03)
Q2 20243($0.03)$0.01($0.02)
Q3 20243($0.05)$0.02($0.02)
Q4 20243($0.06)$0.07$0.00
FY 202412($0.19)$0.08($0.07)

OTLK Earnings Date and Information

Outlook Therapeutics last issued its earnings results on August 14th, 2023. The reported ($0.08) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.04) by $0.04. Outlook Therapeutics has generated $0.00 earnings per share over the last year. Earnings for Outlook Therapeutics are expected to grow in the coming year, from ($0.24) to ($0.11) per share. Outlook Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 13th, 2023 based off prior year's report dates.

Outlook Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/13/2023
Estimated)
------- 
8/14/2023Q3 2023($0.04)($0.08)($0.04)($0.08)--
5/15/2023Q2 2023($0.06)($0.03)+$0.03($0.03)--
2/14/2023Q1 2023($0.04)($0.08)($0.04)($0.08)--
8/10/2022Q3 2022($0.08)($0.08)-($0.08)--
5/13/2022Q2 2022($0.07)($0.09)($0.02)($0.09)--    
2/13/2022Q1 2022($0.06)($0.08)($0.02)($0.08)--    
12/22/2021Q3 2021($0.06)($0.09)($0.03)($0.08)--
8/12/2021Q2 2021($0.07)($0.07)-($0.07)--
5/14/2021Q1 2021($0.10)($0.09)+$0.01($0.09)--
2/16/2021Q4 2020($0.08)($0.12)($0.04)($0.12)--
12/22/2020Q3 2020($0.08)($0.13)($0.05)---












Outlook Therapeutics Earnings - Frequently Asked Questions

When is Outlook Therapeutics's earnings date?

Outlook Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 13th, 2023 based off last year's report dates. Learn more on OTLK's earnings history.

Did Outlook Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Outlook Therapeutics (NASDAQ:OTLK) missed the analysts' consensus estimate of ($0.04) by $0.04 with a reported earnings per share (EPS) of ($0.08). Learn more on analysts' earnings estimate vs. OTLK's actual earnings.

How much profit does Outlook Therapeutics generate each year?

Outlook Therapeutics (NASDAQ:OTLK) has a recorded net income of -$66.05 million. OTLK has generated $0.00 earnings per share over the last four quarters.

What is Outlook Therapeutics's EPS forecast for next year?

Outlook Therapeutics's earnings are expected to grow from ($0.24) per share to ($0.11) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:OTLK) was last updated on 9/23/2023 by MarketBeat.com Staff

My Account -